Determinants of Frailty and Longevity: Are They the Same Ones?

Nestle Nutrition Institute Workshop Series

Volumn 83, Issue , 2015, Pages 29-39

  Rodriguez Manas, Leocadio ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; BIOLOGICAL MODEL; CHRONIC DISEASE; COMPARATIVE STUDY; DISABLED PERSON; FRAIL ELDERLY; GERIATRIC NUTRITION; HUMAN; IMMUNOLOGY; INFLAMMATION; LONGEVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; VERY ELDERLY; WEIGHT REDUCTION;

AGED; AGED, 80 AND OVER; AGING; CHRONIC DISEASE; DISABLED PERSONS; ELDER NUTRITIONAL PHYSIOLOGICAL PHENOMENA; FRAIL ELDERLY; HUMANS; INFLAMMATION; LONGEVITY; MODELS, BIOLOGICAL; RISK FACTORS; WEIGHT LOSS;

EID: 84947209011     PISSN: 16642147     EISSN: 16642155     Source Type: Book Series    
DOI: 10.1159/000382057     Document Type: Article

References (39)

1. Lohman PH, Sankaranarayanan K, Ashby J: Choosing the limits of life. Nature 1992; 357: 185-186.
2. European Commission, Directorate-General for Economic and Financial Affairs: The 2012 Ageing Report: Underlying assumptions and projection methodologies. http://europa.eu/epc/pdf/2012-ageing-report-en.pdf.
3. Manton KG, Gu X: Changes in the prevalence of chronic disability in the United States black and nonblack population above age 65 from 1982 to 1999. Proc Natl Acad Sci USA 2001; 98: 6354-6359.
4. Sagardui-Villamor J, Guallar-Castillon P, Garcia-Ferruelo M, et al: Trends in disability and disability-free life expectancy among elderly people in Spain: 1986-1999. J Gerontol A Biol Sci Med Sci 2005; 60: 1028-1034.
5. Campbell AJ, Buchner DM: Unstable disability and the fluctuations of frailty. Age Ageing 1997; 26: 315-318.
6. Fried LP, Ferrucci L, Darer J, et al: Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004; 59: 255-263.
7. Bortz WM: Biological basis of determinants of health. Am J Public Health 2005; 95: 389-392.
8. Sehl ME, Yates FE: Kinetics of human aging: I. Rates of senescence between ages 30 and 70 years in healthy people. J Gerontol A Biol Sci Med Sci 2001; 56:B198-B208.
9. Fleg JL, Morrell CH, Bos AG, et al: Accelerated longitudinal decline of aerobic capacity in healthy older adults. Circulation 2005; 112: 674-682.
10. Lunney JR, Lynn J, Foley DJ, et al: Patterns of functional decline at the end of life. JAMA 2003; 289: 2387-2392.
11. Yancik R, Ershler W, Satariano W, et al: Report of the National Institute on Aging Task Force on Comorbidity. J Gerontol A Biol Sci Med Sci 2007; 62: 275-280.
12. Lopez-Otin C, Blasco MA, Partridge L, et al: The hallmarks of aging. Cell 2013; 153: 1194-1217.
13. Fontana L, Partridge L, Longo VD: Extending healthy life span-from yeast to humans. Science 2010; 328: 321-326.
14. Mattison JA, Roth GS, Beasley TM, et al: Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature 2012; 489: 318-321.
15. El Assar M, Angulo J, Rodriguez-Manas L: Oxidative stress and vascular inflammation in aging. Free Radic Biol Med 2013; 65: 380-401.
16. Rodier F, Campisi J: Four faces of cellular senescence. J Cell Biol 2011; 192: 547-556.
17. Ressler S, Bartkova J, Niederegger H, et al: p16 INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging Cell 2006; 5: 379-389.
18. Baker DJ, Wijshake T, Tchkonia T, et al: Clearance of p16 INK4a-positive senescent cells delays ageing-associated disorders. Nature 2011; 479: 232-236.
19. Salminen A, Kaarniranta K, Kauppinen A: Inflammaging: disturbed interplay between autophagy and inflammasomes. Aging (Albany NY) 2012; 4: 166-175.
20. Fried LP, Xue QL, Cappola AR, et al: Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. J Gerontol A Biol Sci Med Sci 2009; 64A:1049-1057.
21. Bandeen-Roche K, Walston JD, Huang Y, et al: Measuring systemic inflammatory regulation in older adults: evidence and utility. Rejuvenation Res 2009; 12: 403-410.
22. Compte N, Boudjeltia KZ, Vanhaeverbeek M, et al: Frailty in old age is associated with decreased interleukin-12/23 production in response to toll-like receptor ligation. PLos One 2013; 8:e65325.
23. Qu T, Walston JD, Yang H, Fedarko NS, et al: Upregulated ex vivo expression of stress-responsive inflammatory pathway genes by LPS-challenged CD14+ monocytes in frail older adults. Mech Ageing Dev 2009; 130: 161-166.
24. Pedersen BK, Febbraio MA: Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 2012; 8: 457-465.
25. Bufford TW, Lott DJ, Marzzeti E, et al: Agerelated differences in lower extremity tissue compartments and associations with physical function in older adults. Exp Gerontol 2012; 47: 38-44.
26. Stenholm S, Strandberg TE, Pitkala K, et al: Midlife obesity and risk of frailty in old age during a 22-year follow-up in men and women: the Mini-Finland Follow-Up Survey. J Gerontol A Biol Sci Med Sci 2014; 69: 73-78.
27. Lamberts SW, van den Beld AW, van der Lely AJ: The endocrinology of aging. Science 1997; 278: 419-424.
28. Baylis D, Bartlett DB, Syddall HE, et al: Immune-endocrine biomarkers as predictors of frailty and mortality: a 10-year longitudinal study in community-dwelling older people. Age (Dordr) 2013; 35: 963-971.
29. Laosa O, Alonso C, Castro M, Rodriguez-Manas L: Pharmaceutical interventions for frailty and sarcopenia. Curr Pharm Des 2014; 20: 3068-3082.
30. Enomoto M, Adachi H, Fukami A, et al: Serum dehydroepiandrosterone sulfate levels predict longevity in men: 27-year follow-up study in a community-based cohort (Tanushimaru study). J Am Geriatr Soc 2008; 56: 994-998.
31. Buvat J, Maggi M, Guay A, Torres LO: Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment. J Sex Med 2013; 10: 245-284.
32. Carcaillon L, Blanco C, Alonso-Bouzon C, et al: Sex differences in the association between serum levels of testosterone and frailty in an elderly population: the Toledo Study for Healthy Aging. PLoS One 2012; 7:e32401.
33. Carcaillon L, Garcia-Garcia FJ, Tresguerres JA, et al: Higher levels of endogenous estradiol are associated with frailty in postmenopausal women from the Toledo Study of Healthy Aging. J Clin Endocrinol Metab 2012; 97: 2898-2906.
34. Vina J, Borras C, Gambini J, et al: Why females live longer than males? Importance of the upregulation of longevity-associated genes by oestrogenic compounds. FEBS Lett 2005; 579: 2541-2545.
35. Leng SX, Hung W, Cappola AR, et al: White blood cell counts, insulin-like growth factor-1 levels, and frailty in community-dwelling older women. J Gerontol A Biol Sci Med Sci 2009; 64: 499-502.
36. Klein BEK, Knudtson MD, Lee KE, Klein R: Parents' attained age and biomarkers of aging in their children. Arch Gerontol Geriatr 2009; 49: 284-288.
37. Ho Y-Y, Matteini AM, Beamer B, et al: Exploring biologically relevant pathways in frailty. J Gerontol A Biol Sci Med Sci 2011; 66A:975-979.
38. Risques RA, Arbeev KG, Yashin AI, et al: Leukocyte telomere length is associated with disability in older US population. J Am Geriatr Soc 2010; 58: 1289-1298.
39. Shamsi KS, Pierce A, Ashton AS, et al: Proteomic screening of glycoproteins in human plasma for frailty biomarkers. J Gerontol A Biol Sci Med Sci 2012; 67: 853-864.